Latest news
The Manufacturers Life Insurance Company Raises Stake in Monte Rosa Therapeutics, Inc. $GLUE - MarketBeatMarketBeat · Sat, 08 Aug 2026 09:13:44 GMTJPMorgan Chase & Co. Has Lowered Expectations for Monte Rosa Therapeutics (NASDAQ:GLUE) Stock Price - MarketBeatMarketBeat · Fri, 07 Aug 2026 18:44:16 GMTWells Fargo & Company Lowers Monte Rosa Therapeutics (NASDAQ:GLUE) Price Target to $27.00 - MarketBeatMarketBeat · Fri, 07 Aug 2026 13:59:27 GMTMonte Rosa Therapeutics (NASDAQ: GLUE) posts 2026 net loss on revenue drop - Stock TitanStock Titan · Thu, 06 Aug 2026 11:09:55 GMTMonte Rosa Therapeutics (NASDAQ:GLUE) Shares Down 4.1% After Analyst Downgrade - MarketBeatMarketBeat · Mon, 03 Aug 2026 15:32:32 GMTMonte Rosa Therapeutics (NASDAQ:GLUE) Price Target Lowered to $27.00 at Wedbush - MarketBeatMarketBeat · Mon, 03 Aug 2026 13:52:06 GMTDel Monte Shares Climb on Fresh Fruit Revenue Growth and Reduced Cost Forecast - Briefs FinanceBriefs Finance · Wed, 29 Jul 2026 07:00:00 GMT